XML 95 R75.htm IDEA: XBRL DOCUMENT
v3.20.2

Commitments, Contingent Liabilities and Litigation (Details) $ in Millions |  | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Jul. 28, 2020 plaintiff lawsuit | Jun. 30, 2020 USD ($) | Mar. 31, 2020 USD ($) | Dec. 31, 2019 USD ($) | Sep. 30, 2019 USD ($) | Jun. 30, 2019 USD ($) | Mar. 31, 2019 USD ($) | Dec. 31, 2018 USD ($) | Sep. 30, 2018 USD ($) | Jun. 30, 2020 USD ($) | Jun. 30, 2019 USD ($) | Jun. 30, 2018 USD ($) | Aug. 11, 2020 StateAG lawsuit
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Income from Settlements of Class Action Lawsuits |  |  |  |  |  |  |  |  |  | $ 16.0 | $ 94.0 | $ 22.0 |
Cost of Goods and Services Sold |  |  |  |  |  |  |  |  |  | 146,054.0 | 138,700.0 | 129,628.0 |
Distribution, selling, general and administrative expenses |  | $ 1,137.0 | $ 1,165.0 | $ 1,163.0 | $ 1,107.0 | $ 1,168.0 | $ 1,097.0 | $ 1,064.0 | $ 1,155.0 | 4,572.0 | 4,480.0 | 4,596.0 |
Opioid Total Settlement, Cuyahoga and Summit Counties |  | 215.0 |  |  |  |  |  |  |  | 215.0 |  |  |
Gain (Loss) Related to Litigation Settlement |  |  |  |  |  |  |  |  |  | $ (5,741.0) | $ (36.0) | $ (159.0) |
Opioid Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency, Lawsuits, Number |  |  |  |  |  |  |  |  |  |  |  |  | 3,000
Number of State Attorneys General filing lawsuits | StateAG |  |  |  |  |  |  |  |  |  |  |  |  | 25
Opioid Lawsuits State [Domain] | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency, Lawsuits, Number |  |  |  |  |  |  |  |  |  |  |  |  | 2,800
Product Liability Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits filed | lawsuit | 31 |  |  |  |  |  |  |  |  |  |  |  |
Opioid Litigation, less Cuyahoga and Summit Counties [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated Litigation Liability |  |  |  |  | 5,560.0 |  |  |  |  |  |  |  |
Cash Component For Settlement Framework, Term |  |  |  |  |  |  |  |  |  | 18 years |  |  |
Opioid Litigation, Cuyahoga and Summit Counties [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Gain (Loss) Related to Litigation Settlement |  |  |  |  |  |  |  |  |  | $ (66.0) |  |  |
CVS Health |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum quarterly payment |  |  |  |  |  |  |  |  |  | 45.6 |  |  |
Alameda County [Member] | Product Liability Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plaintiffs | plaintiff | 4,280 |  |  |  |  |  |  |  |  |  |  |  |
Other Jurisdictions [Member] | Product Liability Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plaintiffs | plaintiff | 36 |  |  |  |  |  |  |  |  |  |  |  |
Product Liability Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits filed | lawsuit | 334 |  |  |  |  |  |  |  |  |  |  |  |
Minimum |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency Accrual |  | 468.0 |  |  |  |  |  |  |  | 468.0 |  |  |
Maximum |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency, Estimate of Possible Loss |  | $ 919.0 |  |  |  |  |  |  |  | 919.0 |  |  |
Sterile Surgical Gown Recall [Member] [Domain] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Inventory Recall Expense |  |  |  |  |  |  |  |  |  | 85.0 |  |  |
Cost of Goods and Services Sold |  |  |  |  |  |  |  |  |  | 48.0 |  |  |
Distribution, selling, general and administrative expenses |  |  |  |  |  |  |  |  |  | $ 37.0 |  |  |
Total Opioid Litigation, net of tax [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Gain (Loss) Related to Litigation Settlement |  |  |  |  | (5,140.0) |  |  |  |  |  |  |  |
Total Opioid Litigation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated Litigation Liability |  |  | $ 5,630.0 |  |  |  |  |  |  |  |  |  |
Gain (Loss) Related to Litigation Settlement |  |  |  |  | $ (5,630.0) |  |  |  |  |  |  |  |
Private Parties [Member] | Opioid Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency, Lawsuits, Number | lawsuit |  |  |  |  |  |  |  |  |  |  |  |  | 400
Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingency, Lawsuits, Number | lawsuit |  |  |  |  |  |  |  |  |  |  |  |  | 106

X
- Definition Cash Component For Settlement Framework, Term + References No definition available. + Details
Name: | cah_CashComponentForSettlementFrameworkTerm
Namespace Prefix: | cah_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Income from Settlements of Class Action Lawsuits + References No definition available. + Details
Name: | cah_IncomefromSettlementsofClassActionLawsuits
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Loss Contingency, Lawsuits, Number + References No definition available. + Details
Name: | cah_LossContingencyLawsuitsNumber
Namespace Prefix: | cah_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved. + References No definition available. + Details
Name: | cah_MaximumQuarterlyPayment
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of State Attorneys General filing lawsuits + References No definition available. + Details
Name: | cah_NumberofStateAttorneysGeneralfilinglawsuits
Namespace Prefix: | cah_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Opioid Total Settlement, Cuyahoga and Summit Counties + References No definition available. + Details
Name: | cah_OpioidTotalSettlementCuyahogaandSummitCounties
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a),(d)) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 + Details
Name: | us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_InventoryRecallExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_LitigationReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss contingency liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 + Details
Name: | us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248 + Details
Name: | us-gaap_LossContingencyEstimateOfPossibleLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The total number of new claims filed pertaining to a loss contingency during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of plaintiffs that have filed claims pertaining to a loss contingency. + References No definition available. + Details
Name: | us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=cah_OpioidLawsuitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=cah_CVSHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=cah_AlamedaCountyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cah_PlaintiffTypeAxis=cah_PrivatePartiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |